U
XTNT icon

UBS’s Xtant Medical Holdings XTNT Stock Holding History

UBS’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$10K Buy
202
+27
+15% +$1.79K ﹤0.01% 8851
2014
Q2 		$14K Hold
175
– – ﹤0.01% 8535
2014
Q1 		$18K Sell
175
-204
-54% -$16.1K ﹤0.01% 8248
2013
Q4 		$23K Buy
379
+204
+117% +$13K ﹤0.01% 7978
2013
Q3 		$14K Sell
175
-44
-20% -$3.16K ﹤0.01% 8481
2013
Q2 		$11K Buy
+219
New +$18.1K ﹤0.01% 8554

Other funds holding XTNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS's XTNT Position: Q3 2014 in Review

UBS increased its Xtant Medical Holdings (XTNT) stake by 15% in Q3 2014, buying an estimated $1.79K and bringing the position to 202 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #8851.

UBS first reported a position in XTNT in Q2 2013 and has held it in 6 quarters since. The position peaked at $23K in Q4 2013. 20 funds tracked by Wall St. Rank hold XTNT as of Q3 2014.

  • UBS held 202 shares of Xtant Medical Holdings worth $10K as of Q3 2014.
  • UBS bought 27 Xtant Medical Holdings shares in Q3 2014, an estimated $1.79K.
  • Xtant Medical Holdings made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8851 holding.
  • UBS first reported a position in Xtant Medical Holdings in Q2 2013 and has held it in 6 quarters since.
  • UBS's Xtant Medical Holdings position peaked at $23K in Q4 2013.
  • 20 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.